Inventor · disambiguated record
Philippe G. Nantermet
Also filed as: NANTERMET PHILIPPE · NANTERMET PHILIPPE G
42 granted patents·12 pending applications·227 citations·filing 1993–2022
97Inventor score
Files withMERCK & CO INC11MERCK SHARP & DOHME10SCRIPPS RESEARCH INST8NANTERMET PHILIPPE G5MERCK SHARP & DOHME LLC4
Top patents by PatentIndex Score
54 records- 0190US5817822ACertain alpha-azacycloalkyl substituted arylsulfonamido acetohydroxamic acidsNOVARTIS AG·Filed 1997·Granted Oct 6, 1998·54 cites·20 claims
- 0288US5440057AAccess to taxol analogsSCRIPPS RESEARCH INST·Filed 1993·Granted Aug 8, 1995·31 cites·1 claims
- 0386US7348448B2Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK & CO INC·Filed 2004·Granted Mar 25, 2008·28 cites·13 claims
- 0486US5461169ATotal synthesis of taxol and taxol analogsSCRIPPS RESEARCH INST·Filed 1994·Granted Oct 24, 1995·33 cites·1 claims
- 0580US6403612B2Thrombin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Jun 11, 2002·9 cites·5 claims
- 0677US6515011B2Thrombin inhibitorsMERCK & CO INC·Filed 2001·Granted Feb 4, 2003·11 cites·23 claims
- 0775US6544982B1Thrombin receptor antagonistsMERCK & CO INC·Filed 2000·Granted Apr 8, 2003·5 cites·7 claims
- 0872US10519147B2Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Dec 31, 2019·1 cites·18 claims
- 0972US10221167B2Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·1 cites·46 claims
- 1072US9315475B2HIV protease inhibitorsBEAULIEU CHRISTIAN·Filed 2013·Granted Apr 19, 2016·5 cites·23 claims
- 1171US6515023B2Thrombin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Feb 4, 2003·6 cites·8 claims
- 1271US5481007ATaxoid synthesisSCRIPPS RESEARCH INST·Filed 1994·Granted Jan 2, 1996·11 cites·2 claims
- 1370US7144899B2Thrombin inhibitorsMERCK & CO INC·Filed 2002·Granted Dec 5, 2006·5 cites·9 claims
- 1469US8211904B2Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's diseaseCOBURN CRAIG A·Filed 2006·Granted Jul 3, 2012·1 cites·17 claims
- 1567US12459933B2Compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Nov 4, 2025·0 cites·32 claims
- 1667US5504222ATransformations of taxolSCRIPPS RESEARCH INST·Filed 1994·Granted Apr 2, 1996·9 cites·3 claims
- 1766US8338614B2Tertiary carbinamines having substituted heterocycles which are active as β-secretase inhibitors for the treatment of alzheimer's diseaseMCGAUGHEY GEORGIA B·Filed 2006·Granted Dec 25, 2012·2 cites·7 claims
- 1865US7550481B2Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK & CO INC·Filed 2004·Granted Jun 23, 2009·2 cites·21 claims
- 1965US7354942B2Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK & CO INC·Filed 2004·Granted Apr 8, 2008·3 cites·18 claims
- 2062US12435077B2Oxazolidinone compound and methods of use thereof as an antibacterial agentMERCK SHARP & DOHME LLC·Filed 2021·Granted Oct 7, 2025·0 cites·24 claims
- 2160US2025066379A1Antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2254US7084134B2Thrombin inhibitorsMERCK & CO INC·Filed 2003·Granted Aug 1, 2006·0 cites·9 claims
- 2351US2019233406A1HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELSMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 2451US2007060569A1Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitorsFUJIMOTO ROGER A·Filed 2006·Application pending·0 cites
- 2551US2010113415A1Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancerRAJAPAKSE HEMAKA A·Filed 2009·Application pending·0 cites
- 2650US6043382ATransformations of taxolSCRIPPS RESEARCH INST·Filed 1998·Granted Mar 28, 2000·3 cites·5 claims
- 2749US2024101555A1Urea orexin receptor agonistsARMACOST KIRA A·Filed 2021·Application pending·0 cites
- 2848US7829597B2Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME INC·Filed 2004·Granted Nov 9, 2010·0 cites·17 claims
- 2947US12365656B2Oxazolidinone compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 22, 2025·0 cites·17 claims
- 3047US8492387B22-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's diseaseHILLS IVORY D·Filed 2009·Granted Jul 23, 2013·0 cites·11 claims
- 3147US2010197688A1Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancerNANTERMET PHILIPPE G·Filed 2009·Application pending·0 cites
- 3246US10968210B2Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2017·Granted Apr 6, 2021·0 cites·19 claims
- 3346US7816378B2Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2006·Granted Oct 19, 2010·0 cites·17 claims
- 3445US8008315B2Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2010·Granted Aug 30, 2011·0 cites·20 claims
- 3545US5750691AAccess to taxol analogsSCRIPPS RESEARCH INST·Filed 1995·Granted May 12, 1998·2 cites·2 claims
- 3645US2010093811A1Hiv protease inhibitorsCOBURN CRAIG A·Filed 2008·Application pending·0 cites
- 3745US2004235896A1Certain azacycloalkyl substituted acetic acid derivativesFiled 2002·Application pending·0 cites
- 3844US7820674B2Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2006·Granted Oct 26, 2010·0 cites·17 claims
- 3944US5786489ATransformations of taxolSCRIPPS RESEARCH INST·Filed 1996·Granted Jul 28, 1998·2 cites·3 claims
- 4043US8399473B2Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's diseaseNANTERMET PHILIPPE G·Filed 2007·Granted Mar 19, 2013·0 cites·17 claims
- 4143US7951949B2Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK SHARP & DOHME·Filed 2005·Granted May 31, 2011·0 cites·12 claims
- 4242US7968571B22,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's DiseaseMERCK SHARP & DOHME·Filed 2005·Granted Jun 28, 2011·0 cites·12 claims
- 4341US7026324B2Thrombin inhibitorsMERCK & CO INC·Filed 2002·Granted Apr 11, 2006·0 cites·12 claims
- 4441US2009170830A1Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's DiseaseNANTERMET PHILIPPE G·Filed 2006·Application pending·0 cites
- 4540US5760240ATaxoid synthesisSCRIPPS RESEARCH INST·Filed 1995·Granted Jun 2, 1998·2 cites·1 claims
- 4640US2003158218A1Thrombin inhibitorsFiled 2002·Application pending·0 cites
- 4739US7678783B2Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2005·Granted Mar 16, 2010·0 cites·10 claims
- 4838US6339090B1Alpha 1A adrenergic receptor antagonistsMERCK & CO INC·Filed 1999·Granted Jan 15, 2002·1 cites·22 claims
- 4938US2019209572A1Bifunctional antifungal agents and methods of treating fungal infectionUNIV YALE·Filed 2017·Application pending·0 cites
- 5037US8394837B22,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's diseaseNANTERMET PHILIPPE G·Filed 2005·Granted Mar 12, 2013·0 cites·14 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Philippe G. Nantermet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →